PMID- 9535136 OWN - NLM STAT- MEDLINE DCOM- 19980514 LR - 20190701 IS - 0304-3940 (Print) IS - 0304-3940 (Linking) VI - 243 IP - 1-3 DP - 1998 Feb 27 TI - Activation of non-NMDA receptors stimulates acetylcholine and GABA release from dorsal hippocampus: a microdialysis study in the rat. PG - 152-6 AB - The effect of the non-N-methyl-D-aspartate (NMDA) agonists (RS)-alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) and quisqualate (QUIS) on the release of acetylcholine (ACh), gamma-amino butyric acid (GABA), aspartate (Asp) and glutamate (Glu) from the hippocampus of freely moving rats was studied by transversal microdialysis. Intracerebroventricular (i.c.v.) administration of the non-NMDA receptor agonist AMPA (0.5 nmol) enhanced (by about 200%) ACh release from the hippocampus. The effect of AMPA was completely antagonized by 6-nitro-7-sulphamoyl-benz(f)quinoxaline-2,3-dione (NBQX; 2 nmol, i.c.v). No effect was seen when AMPA was perfused through the septum. However, AMPA (200 microM) locally applied to the hippocampus, increased (by about 200%) ACh release. QUIS (200 microM) applied locally to the hippocampus produced a long-lasting increase in the release of ACh (by about 215%) and GABA (by about 460%). Local infusion of tetrodotoxin (1 microM) decreased ACh and GABA basal extracellular levels, and abolished the QUIS-induced increase in ACh and GABA. Our results demonstrate that non-NMDA glutamatergic receptors in the hippocampus regulate hippocampal release of GABA and ACh. FAU - Giovannini, M G AU - Giovannini MG AD - Department of Preclinical and Clinical Pharmacology, University of Florence, Italy. FAU - Rakovska, A AU - Rakovska A FAU - Della Corte, L AU - Della Corte L FAU - Bianchi, L AU - Bianchi L FAU - Pepeu, G AU - Pepeu G LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Ireland TA - Neurosci Lett JT - Neuroscience letters JID - 7600130 RN - 0 (Excitatory Amino Acid Agonists) RN - 0 (Excitatory Amino Acid Antagonists) RN - 0 (Quinoxalines) RN - 0 (Receptors, AMPA) RN - 118876-58-7 (2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline) RN - 4368-28-9 (Tetrodotoxin) RN - 56-12-2 (gamma-Aminobutyric Acid) RN - 6384-92-5 (N-Methylaspartate) RN - 77521-29-0 (alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid) RN - 8OC22C1B99 (Quisqualic Acid) RN - N9YNS0M02X (Acetylcholine) SB - IM MH - Acetylcholine/*metabolism MH - Animals MH - Excitatory Amino Acid Agonists/pharmacology MH - Excitatory Amino Acid Antagonists/pharmacology MH - Hippocampus/chemistry/drug effects/*metabolism MH - Male MH - Microdialysis MH - N-Methylaspartate/pharmacology MH - Quinoxalines/pharmacology MH - Quisqualic Acid/pharmacology MH - Rats MH - Rats, Wistar MH - Receptors, AMPA/*physiology MH - Tetrodotoxin/pharmacology MH - alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/pharmacology MH - gamma-Aminobutyric Acid/*metabolism EDAT- 1998/04/16 00:00 MHDA- 1998/04/16 00:01 CRDT- 1998/04/16 00:00 PHST- 1998/04/16 00:00 [pubmed] PHST- 1998/04/16 00:01 [medline] PHST- 1998/04/16 00:00 [entrez] AID - S0304-3940(98)00091-3 [pii] AID - 10.1016/s0304-3940(98)00091-3 [doi] PST - ppublish SO - Neurosci Lett. 1998 Feb 27;243(1-3):152-6. doi: 10.1016/s0304-3940(98)00091-3.